HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin K Chen Selected Research

Purinergic P2X1 Receptors

1/2020P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.
1/2019P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin K Chen Research Topics

Disease

22Infections
01/2022 - 05/2006
6HIV Infections (HIV Infection)
03/2016 - 08/2010
4Inflammation (Inflammations)
01/2019 - 10/2014
2Virus Diseases (Viral Diseases)
10/2015 - 10/2014
1Emerging Communicable Diseases (Emerging Infectious Diseases)
11/2020
1COVID-19
11/2020
1Acquired Immunodeficiency Syndrome (AIDS)
01/2012
1Cachexia
01/2012
1Nausea
01/2012
1Neuralgia (Stump Neuralgia)
01/2012
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2010
1Fibrosis (Cirrhosis)
08/2010
1Coinfection
08/2010

Drug/Important Bio-Agent (IBA)

4Neutralizing AntibodiesIBA
01/2022 - 07/2012
3AntibodiesIBA
01/2022 - 01/2017
3Antiviral Agents (Antivirals)IBA
11/2020 - 01/2012
3Glycoproteins (Glycoprotein)IBA
01/2019 - 09/2015
3CytokinesIBA
01/2019 - 08/2010
3Purinergic Receptors (Receptors, Purine)IBA
01/2019 - 10/2014
3Proteins (Proteins, Gene)FDA Link
01/2017 - 12/2013
2EpitopesIBA
01/2022 - 07/2012
23- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA
01/2020 - 01/2019
24,4,',4'',4'''- (carbonylbis(imino- 5,1,3- benzenetriylbis(carbonylimino)))tetrakis(benzene- 1,3- disulfonate)IBA
01/2020 - 01/2019
2Purinergic P2X1 ReceptorsIBA
01/2020 - 01/2019
2Broadly Neutralizing AntibodiesIBA
01/2020 - 01/2017
2Purinergic AntagonistsIBA
01/2018 - 10/2014
1Biotin (Vitamin H)FDA Link
01/2021
1Oxygen (Dioxygen)IBA
11/2020
1VaccinesIBA
11/2020
1NF 279IBA
01/2020
1Interleukin-10 (Interleukin 10)IBA
01/2019
1Zidovudine (Retrovir)FDA LinkGeneric
01/2019
1Purinergic P2X7 ReceptorsIBA
01/2019
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
01/2017
1NigericinIBA
03/2016
1Biological ProductsIBA
03/2016
1Simvastatin (Zocor)FDA LinkGeneric
03/2016
1HIV Fusion InhibitorsIBA
03/2016
1Interleukin-8 (Interleukin 8)IBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
01/2016
1ChemokinesIBA
01/2016
1Amino AcidsFDA Link
09/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1Anti-HIV Agents (AIDS Drugs)IBA
10/2014
1AntigensIBA
01/2013
1Monoclonal AntibodiesIBA
07/2012
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2012
1Green Fluorescent ProteinsIBA
01/2011
1Viral ProteinsIBA
01/2011
1RNA (Ribonucleic Acid)IBA
08/2010
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2010
1CollagenIBA
08/2010
1Complement System Proteins (Complement)IBA
05/2006

Therapy/Procedure

5Therapeutics
11/2020 - 10/2014
1Highly Active Antiretroviral Therapy (HAART)
08/2010